Webinar | If Everyone Has AI, Who Wins SEP Licensing!
3 September | 12:00 PM to 1:00 PM ET: Register Now

Genomadix

Genomadix develops molecular tests in the areas of infectious disease, precision medicine, and water safety testing.
2021
1-10
Kanata, Ontario, Canada
  • Pathology & Diagnostics
  • Personalized Medicine Technologies
  • Water Purifiers

Investment Funding

Last Funding Stage

Corporate Round

Last Funding Date

29-08-2022

Lead Investors

Mayo Clinic

About

Genomadix develops molecular tests in the areas of infectious disease, precision medicine, and water safety testing.

Something missing or incorrect on this page? Help us enrich this information